PDF (Download) |
- Dark Chocolate (Theobroma cacao)
- C-Reactive Protein
- Inflammation
- FasTrak
| Date: 10-31-2008 | HC# 100181-363 |
Re: Effects of Dark Chocolate Consumption on Anti-inflammatory Marker in Healthy Italians
di Giuseppe R, Di Castelnuovo A, Centritto F, et al. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr., 2008;138: 1939-1945.
Cocoa (Theobroma
cacao), a constituent of chocolate, contains high concentrations of
flavonoids, which have been shown to have antioxidant properties. In vitro
studies have shown that cocoa flavanols promote endothelium-dependent vessel
relaxation and modulate the response of cytokines and eicosanoids, which are
involved in the inflammatory response. Clinical studies have shown that dark
chocolate consumption increases serum high-density-lipoprotein (HDL; so-called
"good cholesterol"), but does not affect serum total or
low-density-lipoprotein cholesterol (LDL; so-called "bad
cholesterol"). An observational study showed that habitual cocoa intake
was associated with a reduction in blood pressure, cardiovascular disease (CVD)
risk, and all-cause mortality. The authors hypothesized that the consumption of
dark chocolate would decrease concentrations of C-reactive protein (CRP)—a
marker of inflammation considered an independent indicator of CVD. Thus, the
objective of this study was to evaluate the relation between dark chocolate
consumption and serum CRP concentrations in healthy Italian adults from the
Moli-sani project—an ongoing cohort study of health in Europe.
A total study population of 10,994 men and
women aged ³35 years were
randomly recruited between March 2005 and July 2007. Those with CVD, consuming
a special diet, or undergoing pharmacologic treatment for diabetes,
hypertension, or dyslipidemia were excluded. Of the remaining subjects, 2
subpopulations were extracted: 1317 subjects who never ate chocolate (control
group; 51% men) and 824 subjects who regularly ate dark chocolate (test group;
55% men). Dietary intakes were evaluated by using the food-frequency
questionnaire of the European Prospective Investigation into Cancer and
Nutrition. Body mass index and blood pressure were measured, and fasting blood
samples were collected from all subjects for the measurement of serum lipid,
glucose, and high-sensitivity CRP concentrations. Relations between chocolate
consumption and CRP concentrations were evaluated by univariate and
multivariate-adjusted analyses of variance.
The median intake of dark chocolate in the
test group was 5.7 g/d. Compared with the control group, the test group was
younger; had a lower body mass index and systolic blood pressure; consumed more
nuts, seeds, dairy products, fish, coffee, and tea; and consumed less meat,
alcohol, and refined cereals. Chocolate consumption was positively associated
with total energy intake. Serum CRP concentrations >3 mg/L (indicating
higher levels of inflammation) were higher in the control group (19%) than in
the test group (14%). Age-adjusted serum CRP concentrations were significantly
lower (P < 0.0005) in the test group (1.06–1.20 mg/L) than in the control
group (1.24–1.36 mg/L). [Editor's note: While this statement is correct, the
mis-association of the higher figures with the group having lower values and
vice versa is not correct, as is shown by the reverse figures in Table 4.]
After multivariate adjustment (age, sex, social status, and physical activity),
dark chocolate consumption was still inversely associated with serum CRP
concentrations. A J-shaped dose-response curve was observed between dark
chocolate consumption and serum CRP concentrations; that is, after an initial
decrease in serum CRP with increasing consumption of dark chocolate, the curve
reached a plateau at a higher intake (6.7 g/d, corresponding to 20 g of
chocolate every 3 days) and reversed above this consumption level. Glucose and
lipid concentrations were not significantly different between the test and
control groups.
Dark chocolate consumption was associated
with lower systolic blood pressure, healthier dietary habits, lower serum CRP
concentrations, lower physical activity, higher energy intakes, and lower body
mass index. The cross-sectional nature of the study, however, did not enable
determination of causality, and it is possible that the participants
inaccurately reported their chocolate intakes. The findings suggest that
"regular consumption of small doses of dark chocolate may reduce
inflammation" and thereby potentially lower the risk of an adverse
cardiovascular event The authors recommend that additional studies be conducted
to elucidate the mechanisms responsible for the observed inverse association
between dark chocolate consumption and lower serum CRP concentrations.
—Brenda Milot, ELS |